Ellen Hope Nein, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6201 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-633-5555 |
Dr. Bradley Lembcke, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 3600 Gaston Ave, #550, Dallas, TX 75246 Phone: 214-821-1177 Fax: 214-821-1193 |
Neeraj Kumar Kalra, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-9741 Fax: 214-648-9531 |
Dr. Laura Catalina De Moya Vega, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3500 Gaston Ave, 4 Roberts, Dallas, TX 75246 Phone: 214-820-3000 Fax: 214-820-3022 |
Sirisha Chunduri, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6901 Snider Plz, Ste#130, Dallas, TX 75205 Phone: 214-696-8033 Fax: 214-361-2552 |
Dr. Danny Hsu Yang, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6201 Harry Hines Blved, Dallas, TX 75390 Phone: 214-633-5555 |
Dr. Susan E Kohl, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3600 Gaston Ave, #550, Dallas, TX 75246 Phone: 214-821-1177 Fax: 214-821-1193 |
Dr. George Vinu Ipe, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3417 Gaston Ave, Suite 1100, Dallas, TX 75246 Phone: 469-800-9000 Fax: 469-800-9140 |
Millie Chen, Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 4500 S Lancaster Rd, Dallas, TX 75216 Phone: 214-742-8387 |
Dr. Shubhada Mithilesh, M.D. Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-684-9741 Fax: 214-648-9531 |
Dr. Rebecca Lee Aldridge, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 4500 S Lancaster Rd, Dallas, TX 75216 Phone: 214-742-8387 |
Hema Atluri, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3500 Gaston Ave, 4 Roberts, Dallas, TX 75246 Phone: 713-319-5060 Fax: 214-820-3022 |
Yu Chen, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6201 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-633-5555 |
Utpal Mondal, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 5323 Harry Hines Boulevard, Dallas, TX 75390 Phone: 214-645-0624 Fax: 214-645-0078 |
Jessica Barnes, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6201 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-633-5555 |
Haley Elizabeth Cashon, PA-C Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3500 Gaston Ave, Dallas, TX 75246 Phone: 972-785-5945 |
Mr. Noman A Hussain, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 7777 Forest Lane, Suite B412, Dallas, TX 75230 Phone: 972-566-5560 Fax: 972-566-5562 |
Sumeet Kalra, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-9741 |
Avian D Kidd, M.D. Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 2900 Mckinnon St # 502, Dallas, TX 75201 Phone: 972-505-1584 Fax: 844-582-3627 |
Donald Demetre-wayne Richards Jr., M.D., M.P.H Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6201 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-633-5555 |
News Archive
A new Alimentary Pharmacology & Therapeutics analysis has found a link between the development of inflammatory bowel disease and a past history of weight loss surgery.
Both Committee Chair Sen. Max Baucus, D-Mont., and Ranking Member Sen. Orrin Hatch, R-Utah, are pushing for an overhaul of Medicare's physician payment formula. Meanwhile, Baucus is not "ready to commit" to hold confirmation hearings for the head of the Centers for Medicare and Medicaid Services who has been re-nominated.
Sequella, a clinical-stage pharmaceutical company commercializing novel antibiotics to treat life-threatening infectious diseases, today announced that it has licensed Pfizer Inc's exclusive worldwide rights to develop and commercialize sutezolid, a Phase 2 oxazolidinone antibiotic currently in development for the treatment of tuberculosis.
Three new studies presented today at the International Liver CongressTM 2014 have helped clarify the optimal use of combination therapy with peginterferon and nucleoside analogues (NUCs) to achieve the best treatment outcomes in patients with chronic hepatitis B (CHB).
› Verified 2 days ago